The management team has extensive experience in the healthcare industry and is advised by a group of influential endoscopists.

Peter Johann

Executive Chairman

Pasi Piitunlaninen

CFO

Mike Parrillo

COO

Eric Coolidge

VP Marketing & Sales US

Erwin van Wijk

VP Business Development

Our technology

Our innovative DiLumen® Endoluminal Interventional Platform (EIP) technology transformed the endosurgery landscape.

DiLumen works with your existing endoscopic equipment to enable endoluminal therapeutic procedures such as complex polypectomies.

Its two balloons create a stabilized area within the GI tract, improving control and tissue manipulation in the rectum and colon.

Advisory board members comprised of renowned endoscopist that have guided Lumendi’s preoduct development

Mr. Amyn Haji

Dr. Adolfo Para-Blanco

Dr. Sergey Kantsevoy

Dr. David Diehl

Dr. Stavros Stavropoulos

Dr. Emre Gorgun

Dr. Roberta Maselli

Molham Abdulsamad, MD

As part of our vision to improve healthcare, Lumendi is committed to building and maintaining a culture of ethical behavior and complies with all applicable laws, regulations, and industry standards. We have developed a Corporate Healthcare Compliance Program that is designed to comply with applicable federal and state laws. Our Compliance Program is also in line with industry standards relating to the marketing and promotion of our products. We expect all our employees and agents to act with integrity and to adhere to our Compliance Program in the performance of their duties. *
To the best of our knowledge, Lumendi  LLC., a subsidiary of Lumendi AG, Zug, Switzerland, is in compliance with our Compliance Program, as described here, and with California Health & Safety Code sections 119400 – 119402. For a copy of our Compliance Program and this written declaration of compliance, please call 203-463-2669.